Edition:
United States

People: Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,486.45INR
6:18am EDT
Change (% chg)

Rs172.85 (+7.47%)
Prev Close
Rs2,313.60
Open
Rs2,336.00
Day's High
Rs2,496.50
Day's Low
Rs2,336.00
Volume
319,495
Avg. Vol
55,321
52-wk High
Rs3,394.95
52-wk Low
Rs1,901.65

Reddy, Satish 

Mr. Satish K. Reddy is Chairman of the Board of Dr. Reddy's Laboratories Ltd. He joined the Company in 1993 as Executive Director and since then has held positions of increasing responsibility as Managing Director in 1997 and Vice-Chairman & Managing Director in 2013. Mr. Reddy led the Company’s transition from a uni-focused manufacturer of Active Pharmaceutical Ingredients (APIs) to a company that moved up the value chain with a diverse product portfolio of Finished Dosage Formulations. He oversaw the expansion and the establishment of a strong footprint for Dr. Reddy’s fi nished dosage products in Russia, CIS countries and other emerging markets. Keeping true to the legacy of the founder of the Company, Dr. K Anji Reddy, Mr. K Satish Reddy drives the Company’s Corporate Social Responsibility initiatives. Mr. Reddy holds a degree in Chemical Engineering from Osmania University, Hyderabad and a Masters in Medicinal Chemistry from Purdue University, USA. .

Basic Compensation

Total Annual Compensation, INR 83,320,000
Restricted Stock Awards, INR --
Long-Term Incentive Plans, INR --
All Other, INR 4,710,000
Fiscal Year Total, INR 88,030,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Satish Reddy

88,030,000

G. Prasad

119,220,000

Saumen Chakraborty

39,930,000

Sripada Chandrasekhar

--

Abhijit Mukherjee

14,600,000

Amit Biswas

--
As Of  30 Mar 2016